Local Institution - 0137

Hangzhou, Zhejiang 310016

1 studies enrolling now · 2 studies all time

What they study most

Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Colorectal Cancer, Metastatic Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) — Running, not enrolling